Newsletter Signup x

Does a harmless virus hold the key to delivering treatment for DIPG?

Paediatric diffuse intrinsic pontine glioma (DIPG) is a highly aggressive tumour, found at the base of the brain. Despite developments in cancer treatments – both in terms of new drugs and delivery methods – it remains very hard to treat, and the outlook for children with this cancer is poor.
In particular, the way that DIPG diffuses, or spreads, within ...

Read more

Seeking new ways to deliver drugs to brain tumours in children

Childhood brain tumours have remained difficult to treat, despite many advances in cancer treatments in recent years. One important reason for this is the blood-brain barrier (BBB). The BBB is intended to protect the brain, but, when intact and functional, this protection also prevents anti-cancer drugs from achieving effective concentrations in the brain tumour.
Doctors and scientists from hospitals and ...

Read more

£3.74m Precision Medicine funding

We’re proud to be providing £3.74m funding for Precision Medicine, targeting less toxic cancer treatments. In July 2017, we began funding £1.5m for Precision Medicine research, targeting less toxic cancer treatments. In October 2018, we were proud to increase our Precision Medicine funding to £3.74m.
Precision Medicine is an exciting new way to deliver cancer treatment to children. It takes into ...

Read more

Analysing the precise genetic characteristics of tumours

Detailed analysis of the genetic characteristics of a child’s tumour can provide doctors with lots of information about the tumour and how best to treat it. This is known as precision medicine, and this project aims to put in place the infrastructure necessary to introduce the systematic testing of newly diagnosed and relapsed children.
Our funding is enabling doctors to ...

Read more